PharmaCyte Biotech Inc (OTCMKTS:PMCBD – Get Free Report) traded up 0.6% during trading on Monday . The stock traded as high as $2.00 and last traded at $1.80. 69,343 shares traded hands during mid-day trading, an increase of 685% from the average session volume of 8,831 shares. The stock had previously closed at $1.79.
PharmaCyte Biotech Stock Up 0.6 %
The business has a fifty day moving average of $1.74 and a 200 day moving average of $1.95.
About PharmaCyte Biotech
PharmaCyte Biotech, Inc is a clinical stage biotechnology company, which engages in the development and commercialization of treatments for cancer and diabetes. It focuses on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box, which will be used as a platform for the development of treatments for inoperable pancreatic cancer and other solid cancerous tumors, and diabetes.
Featured Articles
- Five stocks we like better than PharmaCyte Biotech
- What is a support level?
- Inflation Risk Rising, Key Trades Investors Are Making Now
- What Does a Stock Split Mean?
- 3 Oil Stocks to Watch Before Earnings Come Out
- Retail Stocks Investing, Explained
- Is American Express Stock’s Sell-the-News Reaction a Buying Opp?
Receive News & Ratings for PharmaCyte Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PharmaCyte Biotech and related companies with MarketBeat.com's FREE daily email newsletter.
